Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
james hill (Dundee, United Kingdom), James Hill, Duncan Renton, Hani Abo-Leyah, Megan Crichton, Simon Finch, Thomas Fardon, James Chalmers. Idiopathic and post-infective bronchiectasis show no clinically important differences in outcomes or airway inflammatory profiles. Eur Respir J 2015; 46: Suppl. 59, 466

Member's Comments

No comment yet.

Related content which might interest you: Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation? Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Bronchiectasis associated with inflammatory bowel disease Source: Eur Respir Mon 2011; 52: 163-177 Year: 2011 Characteristic of a subgroup of non cystic fibrosis bronchiectasis with concomitant asthma Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Positive microbiology findings in non-cystic fibrosis bronchiectasis and co-morbidities Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Patients hospitalised with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Thrombocytosis is associated with disease severity and outcomes in stable bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Microbiological factors of acute attack in patients with bronchiectasis Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013 Predictors of lung function decline in stable non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Exacerbations in non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Clinical phenotypes in non-cystic fibrosis bronchiectasis (NCFBE) Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 The clinical features of asthma-COPD overlap syndrome compared to asthma with irreversible airway obstruction Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Viral and bacterial etiology of severe COPD exacerbations: relationship with airway inflammation Source: Eur Respir J 2005; 26: Suppl. 49, 251s Year: 2005 Bronchiectasis prevalence and relationship with clinical features in COPD Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Exacerbations of bronchiectasis requiring hospitalization; clinical characteristics and outcomes Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Microbial aetiology and outcomes of CAP in bronchiectatic patients Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Co-existent rheumatoid arthritis and non-cystic fibrosis bronchiectasis: Evidence for more severe pulmonary disease using the bronchiectasis severity index (BSI) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Multiple inflammatory hits and the pathogenesis of severe airway disease Source: Eur Respir J 2006; 27: 884-888 Year: 2006 Bacterial etiology of exacerbations of non-cystic fibrosis bronchiectases in young patients Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Diagnosis and aetiological treatment of bronchiectasis in adult patients Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation Year: 2015 Differences in clinical features and biomarkers of subsequent acute cystic fibrosis pulmonary exacerbations - Analysing exacerbations as separate entities Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013